| Literature DB >> 18217556 |
Raoul E Nap1, Maarten P H M Andriessen, Nico E L Meessen, Tjip S van der Werf.
Abstract
Using estimates from the Centers for Disease Control and Prevention, the World Health Organization, and published models of the expected evolution of pandemic influenza, we modeled the surge capacity of healthcare facility and intensive care unit (ICU) requirements over time in northern Netherlands (approximately 1.7 million population). We compared the demands of various scenarios with estimates of maximum ICU capacity, factoring in healthcare worker absenteeism as well as reported and realistic estimates derived from semistructured telephone interviews with key management in ICUs in the study area. We show that even during the peak of the pandemic, most patients requiring ICU admission may be served, even those who have non-influenza-related conditions, provided that strong indications and decision-making rules are maintained for admission as well as for continuation (or discontinuation) of life support. Such a model should be integral to a preparedness plan for a pandemic with a new human-transmissible agent.Entities:
Mesh:
Year: 2007 PMID: 18217556 PMCID: PMC3375786 DOI: 10.3201/eid1311.070103
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Age distribution of inhabitants of 3 northern provinces in the study, the Netherlands
| Province | Age range, y | Total, all ages | ||||
|---|---|---|---|---|---|---|
| 0–15 | 16–24 | 25–44 | 45–64 | |||
| Groningen | 99,065 | 72,714 | 164,371 | 151,590 | 86,818 | 574,558 |
| Friesland | 125,174 | 70,397 | 174,768 | 172,600 | 99,665 | 642,604 |
| Drenthe | 92,241 | 45,885 | 127,674 | 136,915 | 81,212 | 483,927 |
| Total | 316,480 | 188,996 | 466,813 | 461,105 | 267,695 | 1,701,089 |
Avian influenza impact for 3 northern provinces in the Netherlands*
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 0 | 1–7 | 0 | 0 | 0 | 0 |
| 1 | 8–14 | 105 | 11 | 0 | 0 |
| 2 | 15–21 | 4,694 | 515 | 11 | 0 |
| 3 | 22–28 | 145,898 | 16,559 | 315 | 84 |
| 4 | 29–35 | 347,288 | 44,699 | 977 | 420 |
| 5 | 36–42 | 25,935 | 3,696 | 95 | 74 |
| 6 | 43–49 | 578 | 84 | 0 | 0 |
| 7 | 50–56 | 11 | 0 | 0 | 0 |
| 8 | 57–63 | 0 | 0 | 0 | 0 |
| 9 | 64–70 | 0 | 0 | 0 | 0 |
| Total | 524,507 | 65,562 | 1,397 | 578 |
*30% attack rate, pandemic period 9 weeks.
Figure 1A) 30% attack rate and mean length of stay of 8 days without antiviral medication, pandemic period 9 weeks; B) 30% attack rate and mean length of stay of 8 days with antiviral medication, pandemic period 14 weeks; C) 30% attack rate and mean length of stay of 15 days without antiviral medication, pandemic period 9 weeks; D) 30% attack rate and mean length of stay of 15 days with antiviral medication, pandemic period 14 weeks.
Figure 2A) Effect of intensified treatment decision (25% intensive care unit [ICU] admission rate, mean length of stay of 8 days) without antiviral medication, pandemic period 9 weeks; B) effect of intensified treatment decision (50% ICU admission rate, mean length of stay of 8 days) without antiviral medication, pandemic period 9 weeks.